225 related articles for article (PubMed ID: 15665710)
1. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study.
Paul ME; Chantry CJ; Read JS; Frederick MM; Lu M; Pitt J; Turpin DB; Cooper ER; Handelsman EL
Pediatr Infect Dis J; 2005 Jan; 24(1):46-56. PubMed ID: 15665710
[TBL] [Abstract][Full Text] [Related]
2. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
[TBL] [Abstract][Full Text] [Related]
3. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
Newell ML; Borja MC; Peckham C;
Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
[TBL] [Abstract][Full Text] [Related]
4. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
[TBL] [Abstract][Full Text] [Related]
6. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
8. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
9. Prospective cohort study of children born to human immunodeficiency virus-infected mothers, 1985 through 1997: trends in the risk of vertical transmission, mortality and acquired immunodeficiency syndrome indicator diseases in the era before highly active antiretroviral therapy.
Simpson BJ; Shapiro ED; Andiman WA
Pediatr Infect Dis J; 2000 Jul; 19(7):618-24. PubMed ID: 10917219
[TBL] [Abstract][Full Text] [Related]
10. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
[TBL] [Abstract][Full Text] [Related]
11. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
[TBL] [Abstract][Full Text] [Related]
13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
14. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
15. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
16. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.
Bamji M; Thea DM; Weedon J; Krasinski K; Matheson PB; Thomas P; Lambert G; Abrams EJ; Steketee R; Heagarty M
Pediatr Infect Dis J; 1996 Oct; 15(10):891-8. PubMed ID: 8895922
[TBL] [Abstract][Full Text] [Related]
18. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
Fouché C; van Niekerk E; du Plessis LM
Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.
Benhammou V; Warszawski J; Bellec S; Doz F; André N; Lacour B; Levine M; Bavoux F; Tubiana R; Mandelbrot L; Clavel J; Blanche S;
AIDS; 2008 Oct; 22(16):2165-77. PubMed ID: 18832880
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
